This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
This update of ECDC’s rapid risk assessment on the Zika epidemic considers the recent epidemiological and scientific information in light of the risk to Europe and European citizens.
This seventh update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, as well as the risk of local vector-borne transmission in Europe during the 2016 summer season.
A team of experts from ECDC and four EU countries (France, Italy, Portugal and Spain) visited Malta from 3 to 6 July 2016 and met with staff from the Ministry of Health and key stakeholders in Malta to discuss preparedness planning for mosquito-borne diseases.
This document highlights preparedness measures that should be in place to minimise the risk of Zika virus spreading in continental Europe, primarily to protect pregnant women and women who wish to become pregnant, considering the evidence of the association between Zika virus and congenital malformations of the brain of the developing foetus.
This document updates ECDC’s initial assessment of the potential health risks related to communicable diseases and other health threats for European citizens during the 2016 Olympic and Paralympic Summer Games in Rio de Janeiro, Brazil.
This sixth update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, taking account the latest information available.
This update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, taking account of the latest information available.
The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States.